US7444132044
US7444132044
P3 Health Partners Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.01B EUR | 42.23M EUR | 10.15M EUR | 11.47M EUR |
Enterprise Value | 360.08M EUR | 151.65M EUR | 307.32M EUR | 271.34M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -23.57x | -- | -- | -- |
Price to Sales | 0.67x | 0.03x | 0.01x | 0.01x |
Price to Book | -- | 0.58x | -- | -- |
EV/Revenue | 0.24x | 0.1x | 0.21x | 0.25x |
EV/EBITDA | -5.58x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -12.32% | -309.08% | -840.09% | -503.69% |